Fei Song

884 citations
36 papers · 547 indexed · h-index 14
Topics
Immune Cell Function and Interaction (5 papers)Immunotherapy and Immune Responses (3 papers)Atherosclerosis and Cardiovascular Diseases (3 papers)
Partner nations
ChinaUnited StatesJapan

In The Last Decade

Fei Song

31 papers receiving 537 citations

Peers

Fei Song
Comparison fields: 5 of 89
  • Immunology 154
  • Molecular Biology 120
  • Epidemiology 93
  • Surgery 88
  • Cardiology and Cardiovascular Medicine 57
Replace Ivy Ka Man Law with:
Ivy Ka Man Law United States
Soh-Hyun Lee United States
Katarzyna Neubauer Poland
Sergio López-Briones Mexico
Fang Xiao China
Kazuki Kakimoto Japan
Lina Zhang China
Fei Song relative to Ivy Ka Man Law United States Ivy Ka Man Law's profile →
Citations per field
00.5×1.5×
Ivy Ka Man Law · 1×
Citations per year

Countries citing papers authored by Fei Song

Since Specialization
Citations

This map shows the geographic impact of Fei Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Song more than expected).

Fields of papers citing papers by Fei Song

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Song. The network helps show where Fei Song may publish in the future.

Co-authorship network of co-authors of Fei Song

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Song. A scholar is included among the top collaborators of Fei Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Song. Fei Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 6
5 6
6 4
7 1
8 2
9 30
10 0
11 21
12 29
13 47
14
[Focused low-intensity extracorporeal shock wave therapy for erectile dysfunction: Preliminary observation of 32 cases].
4
15 1
16 19
17 27
18 23
19 76
20 1

About Fei Song

Fei Song is a scholar working on Immunology, Hematology and Genetics, having authored 36 papers that have together received 547 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (5 papers), Immunotherapy and Immune Responses (3 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). The work is most often cited by research in Immunology (154 citations), Geriatrics and Gerontology (23 citations) and Hematology (38 citations). Fei Song has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Timothy L. Denning, Peter B. Ernst, Hanny Al‐Samkari, Gary R. Klimpel, Wei‐Yin Wu, Yi‐Xiang Hong, Roberto P. Garofalo, Gui‐Rong Li, Nicola Campbell and Komei Ito. Their work appears in journals such as The Journal of Immunology, The Journal of Clinical Endocrinology & Metabolism and Journal of neurosurgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026